Medicamen Biotech Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹47.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.02 per cent from ₹60.65 crore. This corresponds to a year-on-year *(YoY) growth of 11.29 per cent.
Operating Profit
Operating Profit stands at ₹4.33 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 20.40 per cent from ₹5.44 crore. This corresponds to a year-on-year *(YoY) decline of 6.07 per cent.
PBDT
PBDT stands at ₹4.37 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.64 per cent from ₹6.79 crore. This corresponds to a year-on-year *(YoY) growth of 11.20 per cent.
Profit Before Tax
Profit Before Tax stands at ₹2.58 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 49.01 per cent from ₹5.06 crore. This corresponds to a year-on-year *(YoY) growth of 21.13 per cent.
Net Profit
Net Profit stands at ₹1.85 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 58.43 per cent from ₹4.45 crore. This represents a 15.63 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Medicamen Biotech Ltd Earnings
- YOY
- QOQ
Medicamen Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Medicamen Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Medicamen Biotech Ltd Financial Reports
Medicamen Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Medicamen Biotec | 1.07% | 16.76% | 32.56% | 39.96% | 11.70% | -9.24% |
| Aptus Pharma | -2.00% | 3.98% | 23.96% | 51.11% | 178.08% | 881.73% |
| Albert David | 0.32% | -0.87% | 7.76% | 22.12% | 23.28% | 5.88% |
| Jenburkt Pharma | 0.67% | 1.00% | -1.91% | -9.75% | 4.47% | -2.31% |
| Trident Lifeline | 0.52% | -0.77% | 12.61% | 20.69% | 17.31% | 0.07% |
| Astal Lab | -0.52% | 0.00% | -11.46% | -1.11% | 2.55% | -6.22% |
| Ambalal Sarabhai | -0.82% | -3.59% | -7.73% | 33.72% | 68.67% | 32.17% |
Company Info
Company Information
Chairman & Non Executive Dir. : Rahul Bishnoi
Non-Exec & Non-Independent Dir : Vimal Kumar Shrawat
Non-Exec & Non-Independent Dir : S K Singh
Non-Exec & Non-Independent Dir : Ashwani Kumar Sharma
Non-Exec & Non-Independent Dir : Sanjay Bansal
Independent Non Exe. Director : Harish Pande
Independent Non Exe. Director : Arun Kumar
Independent Non Exe. Director : Sumita Dwivedi
Independent Non Exe. Director : Sangeeta Bishnoi
Independent Non Exe. Director : Ravi Kumar Bansal
Independent Non Exe. Director : SHAM GOEL
Independent Non Exe. Director : SHAIVAL SAURABH
Company Sec. & Compli. Officer : Parul Choudhary